Dr. Potz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
201 Gibraltar Rd
Ste 120
Horsham, PA 19044Phone+1 215-706-2034Fax+1 215-706-4176- Is this information wrong?
Education & Training
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1992
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1982 - 1985
- Tufts University School of MedicineClass of 1982
Certifications & Licensure
- PA State Medical License 1993 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
- Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01
- Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) Start of enrollment: 2021 Apr 15
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsMetastatic prostatic adenocarcinoma within a primary solid papillary carcinoma of the male breast.Sunati Sahoo, Roberta E. Smith, Joseph L. Potz, Paul Peter Rosen> ;Archives of Pathology & Laboratory Medicine. 2001 Aug 1
- 711 citationsFunctional regions of the envelope glycoprotein of human immunodeficiency virus type 1Mark Kowalski, Joseph Potz, Ladan Basiripour, Tatyana Dorfman, Wei Chun Goh, Ernest Terwilliger, Andrew Dayton, Craig A. Rosen, William A. Haseltine, Joseph Sodroski> ;Science. 1987 Sep 11
- Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content.Weaver, C. H., Potz, J., Redmond, J., Tauer, K., Schwartzberg, L. S., Kaywin, P., Drapkin, R., Grant, B., Unger, P., Allen, C., Longin, K., Zhen, B., Hazelton, B., Buc...> ;Bone Marrow Transplant. 1997 Jun
- Join now to see all
Hospital Affiliations
- Jefferson Abington HealthAbington, Pennsylvania
- Holy Redeemer HospitalJenkintown, Pennsylvania
- Temple University HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: